78. Finkelstein EA, Khavjou OA, Thompson H, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med 2012 42: 563–570. 79. Ng SW, Popkin BM. Time use and physical activity: a shift away from movement across the globe. Obes Rev Off J Int Assoc Study Obes 2012 13: 659–680. 80. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep 2018 20: 12. 81. Guazzi M, Myers J, Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 2005 46: 1883–1890. 82. Guazzi M, Belletti S, Tumminello G, et al. Exercise hyperventilation, dyspnea sensation, and ergoreflex activation in lone atrial fibrillation. Am J Physiol Heart Circ Physiol 2004 287: H2899–H2905. 83. Aaron CP, Hoffman EA, Lima JAC, et al. Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study. PloS One 2017 12: e0176180. 84. Sugimoto T, Bandera F, Generati G, et al. Left atrial function dynamics during exercise in heart failure: pathophysiological implications on the right heart and exercise ventilation inefficiency. JACC Cardiovasc Imaging 2017 10: 1253–1264. 85. Bonnevie T, Gravier F-E, Ducrocq A, et al. Exercise testing in patients with diaphragm paresis. Respir Physiol Neurobiol 2017 248: 31–35. 86. Brubaker PH, Kitzman DW. Chronotropic incompetence: causes, consequences, and management. Circulation 2011 123: 1010–1020. 87. Chlif M, Temfemo A, Keochkerian D, et al. Advanced mechanical ventilatory constraints during incremental exercise in class iii obese male subjects. Respir Care 2015 60: 549–560. 88. Oldham WM, Lewis GD, Opotowsky AR, et al. Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing. Pulm Circ 2016 6: 55–62. 89. Bhella PS, Prasad A, Heinicke K, et al. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail 2011 13: 1296–1304. 90. Abudiab MM, Redfield MM, Melenovsky V, et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 2013 15: 776–785. 91. Kovacs G, Herve P, Barbera JA, et al. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Eur Respir J 2017 50: 1700578. 92. Huang W, Resch S, Oliveira RK, et al. Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center. Eur J Prev Cardiol 2017 24: 1190–1199. 93. Berry NC, Manyoo A, Oldham WM, et al. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ 2015 5: 610–618. 94. Guazzi M, Naeije R, Arena R, et al. Echocardiography of right ventriculoarterial coupling combined with cardiopulmonary exercise testing to predict outcome in heart failure. Chest 2015 148: 226–234. 95. Bandera F, Generati G, Pellegrino M, et al. Role of right ventricle and dynamic pulmonary hypertension on determining ΔVO2/ΔWork Rate flattening: insights from cardiopulmonary exercise test combined with exercise echocardiography. Circ Heart Fail 2014 7: 782–790. 96. Finocchiaro G, Haddad F, Knowles JW, et al. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. JACC Heart Fail 2015 3: 408–418. 97. Nedeljkovic I, Banovic M, Stepanovic J, et al. The combined exercise stress echocardiography and cardiopulmonary exercise test for identification of masked heart failure with preserved ejection fraction in patients with hypertension. Eur J Prev Cardiol 2016 23: 71–77. 98. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984 129: S49–S55. 99. Zacarias EC, Neder JA, Cendom SP, et al. Heart rate at the estimated lactate threshold in patients with chronic obstructive pulmonary disease: effects on the target intensity for dynamic exercise training. J Cardpulm Rehabil 2000 20: 369–376. 100. Neder JA, Arbex FF, Alencar MCN, et al. Exercise ventilatory inefficiency in mild to end-stage COPD. Eur Respir J 2015 45: 377–387. 101. Casaburi R, Porszasz J. Constant work rate exercise testing: a tricky measure of exercise tolerance. COPD 2009 6: 317–319. 102. Neder JA, Jones PW, Nery LE, et al. Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship. Am J Respir Crit Care Med 2000 162: 497–504. 103. Whipp BJ, Ward SA. Quantifying intervention-related improvements in exercise tolerance. Eur Respir J 2009 33: 1254–1260. 104. Puente-Maestu L, Villar F, de Miguel J, et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J 2009 34: 340–345. 105. Cooper BG, Stocks J, Hall GL, et al. The Global Lung Function Initiative (GLI) Network: bringing the world’s respiratory reference values together. Breathe 2017 13: e56–e64. xxiv https://doi.org/10.1183/2312508X.10015318